Trendingnow
Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026


By Sasha RogelbergAugust 28, 2026

By Kaitlyn Huamani and The Associated PressAugust 28, 2026

By Kamal AhmedAugust 27, 2026

By Catherina GioinoAugust 28, 2026
Latest stories from Fortune
More TechPage 51 of 100

By Lily Mae LazarusMay 29, 2026

By Hebron SherMay 29, 2026

By Matt Rosenbaum and Allan SchweyerMay 29, 2026

By Nick LichtenbergMay 29, 2026

By Jake AngeloMay 29, 2026

By Phil WahbaMay 29, 2026

By Shawn TullyMay 29, 2026

By Eva RoytburgMay 28, 2026

By Jeremy KahnMay 28, 2026

By Sasha RogelbergMay 28, 2026

By Emma BurleighMay 28, 2026

By Preston ForeMay 28, 2026

By Claire ZillmanMay 28, 2026

By Catherina GioinoMay 28, 2026

By Rob GiglioMay 28, 2026

By Yuri Kageyama and The Associated PressMay 28, 2026

By Allen Breed, Holly Ramer and The Associated PressMay 28, 2026

By Eleanor PringleMay 28, 2026

By Serguei Netessine, Valery Yakubovich, Gary Dushnitsky and Claudio GarciaMay 28, 2026

By Andrew NuscaMay 28, 2026

By Nick LichtenbergMay 28, 2026

By Jake AngeloMay 28, 2026

By Shawn TullyMay 28, 2026

By Jeremy KahnMay 28, 2026

By Jeremy KahnMay 28, 2026
Most Popular






















